This book investigates the intricate balance between therapeutic efficacy and potential risks associated with hypolipidemic drugs. It aims to provide a framework for clinicians to navigate the complex landscape of cholesterol-lowering medications, emphasizing a rational approach to patient care. The work draws upon clinical trial data and pharmacological research to delineate the specific benefits and drawbacks of various drug classes. Ultimately, it seeks to empower medical professionals in making informed decisions tailored to individual patient profiles.

This text is likely regarded as a specialized, in-depth resource for medical professionals involved in cardiovascular disease management and pharmacology. Its focus on therapeutic selectivity and risk/benefit assessment suggests a clinical and evidence-based approach, appealing to practitioners seeking detailed guidance on lipid-lowering drug therapy. The publication date indicates it may represent foundational knowledge in the field, potentially serving as a reference for understanding the historical development and early considerations of these medications.